Pulmonary arterial hypertension in systemic sclerosis-when criteria and pathobiology differ

Rheumatology (Oxford). 2020 May 1;59(5):1177-1179. doi: 10.1093/rheumatology/kez474.

Authors

Kristofer Andréasson¹, Göran Rådegran², Hans Brunnström³, Dirk M Wuttge¹, Roger Hesselstrand¹

Affiliations

¹ Department of Clinical Sciences, Lund, Section for Rheumatology.
² Department of Clinical Sciences, Lund, Section for Cardiology.
³ Department of Clinical Sciences, Lund, Section for Pathology, Lund University and Skåne University Hospital, Lund, Sweden.

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Biopsy, Needle
Cardiac Catheterization / methods
Disease Progression
Female
Humans
Immunohistochemistry
Middle Aged
Prognosis
Pulmonary Arterial Hypertension / complications*
Pulmonary Arterial Hypertension / diagnostic imaging
Pulmonary Arterial Hypertension / pathology*
Risk Assessment
Sampling Studies
Scleroderma, Systemic / complications*
Scleroderma, Systemic / diagnostic imaging
Scleroderma, Systemic / pathology*
Severity of Illness Index
Survival Rate
Sweden
Tomography, X-Ray Computed / methods*